|
|
Xenexus Pharmaceuticals, drugs, treatment, neurological disorders, alzheimer's, parkinson's, multiple sclerosis, MS
Xenexus Pharmaceuticals was founded to develop innovative drugs for the treatment of neurological disorders.
The drugs target acute indications such as stroke and traumatic brain injury, as well as chronic conditions such as Alzheimer's disease, Parkinson's disease and multiple sclerosis.
Xenexus is also developing new compounds for the treatment of rheumatoid arthritis and acute respiratory distress syndrome.
|
|
|
